5-Bromo-2,4-Dichloropyrimidine CAS 36082-50-5 Kemurnian >99,0% (GC) Pabrik Menengah Palbociclib
Ruifu Chemical Supply Palbociclib Related Intermediates:
Palbociclib CAS 571190-30-2
5-Bromo-2,4-Dichloropyrimidine CAS 36082-50-5
5-Bromo-2-Chloro-N-Cyclopentylpyrimidin-4-Amine CAS 733039-20-8
tert-Butil 4-(6-Nitropyridin-3-yl)piperazin-1-Karboksilat CAS 571189-16-7
tert-Butyl 4-(6-Amino-3-Pyridyl)piperazine-1-Carboxylate CAS 571188-59-5
6-Bromo-2-Chloro-8-Cyclopentyl-5-Methylpyrido-[2,3-d]pirimidin-7(8H)-siji CAS 1016636-76-2
2-Chloro-8-Cyclopentyl-5-Methyl-8H-Pyrido[2,3-d]pirimidin-7-siji CAS 1013916-37-4
Jeneng Kimia | 5-Bromo-2,4-Dichloropyrimidine |
Nomer CAS | 36082-50-5 |
Nomer CAT | RF-PI1852 |
Status Simpenan | Ing Simpenan, Skala Produksi Nganti Ton |
Formula Molekul | C4HBrCl2N2 |
Bobot Molekul | 227.87 |
Titik didih | 128 ℃ / 15 mmHg (lit.) |
Kapadhetan | 1,781 g/mL ing 25 ℃ (lit.) |
Indeks bias | n20/D 1.603 (lit.) |
Kelarutan | Larut ing Metanol |
Merk | Kimia Ruifu |
Item | Spesifikasi |
Penampilan | Cairan ora ana warna nganti kuning cahya |
Kemurnian / Metode Analisis | > 99,0% (GC) |
Titik Lebur | 29.0~30.0 ℃ |
Banyu (dening Karl Fischer) | <0,50% |
2,4-Dichloropyrimidine | <0,50% (GC) |
Pengotor Tunggal Maksimum | <0,50% (GC) |
Total Impurities | <1.00% |
1 H NMR Spektrum | Konsisten karo Struktur |
Test Standar | Standar Perusahaan |
Panggunaan | Penengah Palbociclib (CAS: 571190-30-2) |
Paket: Botol Fluorinated, 25kg / Drum, utawa miturut kabutuhan pelanggan
Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya lan Kelembapan
5-Bromo-2,4-Dichloropyrimidine (CAS: 36082-50-5) bisa digunakake minangka reagen wiwitan kanggo sintesis modulator alosterik positif kanggo reseptor GABAB (kelas senyawa kaya obat) lan analog pyridinepyrimidine.5-Bromo-2,4-Dichloropyrimidine bisa digunakake minangka perantara saka Palbociclib (CAS: 571190-30-2).Palbociclib (uga dikenal minangka nomer senyawa PD-0332991) minangka obat eksperimental kanggo perawatan kanker payudara sing dikembangake dening Pfizer.Palbociclib minangka inhibitor selektif saka kinase sing gumantung karo cyclin CDK4 lan CDK6.